Vivani Medical Announces Public Filing of Registration Statement for the Proposed Initial Public Offering of Cortigent, Inc., a Subsidiary Advancing the Business of its Neuromodulation Division ...
Vivani Medical, Inc., an innovative, near-clinical stage biopharmaceutical company that is developing novel, miniature, long-term therapeutic implants, announced today that its wholly-owned ...
Vivani Medical, Inc. (NASDAQ: VANI) (the “Company” or “Vivani”), an innovative, clinical-stage biopharmaceutical company that develops novel, long-ter ...
Insiders who bought Vivani Medical, Inc. (NASDAQ:VANI) stock in the last 12 months were richly rewarded last week. The company's market value increased by US$19m as a result of the stock's 38% ...
About Cortigent Cortigent, formerly Second Sight Medical Products, Inc. and a wholly owned subsidiary of Vivani, is developing brain implant devices to help people recover critical body functions.
A high-level overview of Vivani Medical, Inc. WT EXP 031424 (VANIW) stock. View (VANIW) real-time stock price, chart, news, analysis, analyst reviews and more.
Vivani Medical, Inc. (NASDAQ: VANI) (“Vivani” or the “Company”), a clinical-stage biopharmaceutical company developing miniature, ultra long-acting drug implants, announced today that it ...
On April 15, 2025, Vivani and Okava Pharmaceuticals, Inc. ("Okava"), a clinical-stage company focused on the treatment of age-related diseases in dogs and cats, announced an expansion of their ...
Those following along with Vivani Medical, Inc. (NASDAQ:VANI) will no doubt be intrigued by the recent purchase of shares by Gregg Williams, Director of the company, who spent a stonking US$1.8m ...
Cortigent, formerly Second Sight Medical Products, Inc. and a wholly owned subsidiary of Vivani, is developing brain implant devices to help people recover critical body functions.
Vivani Medical, Inc. 競合他社・同業他社分析 - Industrial Applications and Services セクター
Our AI model demonstrates 49% historical accuracy for VANI predictions, based on advanced machine learning algorithms trained on over 10 years of market data.
VAR_0__株価予測に影響を与える要因は何か?
当社の分析では、Vivani Medical, Inc.の財務指標、Industrial Applications and Servicesセクターの動向、市場センチメント、テクニカル指標、業績データ、株価に影響を与えるマクロ経済要因を考慮しています。